• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外成肌细胞和分化肌管中反义寡核苷酸在非辅助摄取后的细胞内分布及核活性

Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro.

作者信息

González-Barriga Anchel, Nillessen Bram, Kranzen Julia, van Kessel Ingeborg D G, Croes Huib J E, Aguilera Begoña, de Visser Peter C, Datson Nicole A, Mulders Susan A M, van Deutekom Judith C T, Wieringa Bé, Wansink Derick G

机构信息

1 Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands .

2 BioMarin Nederland B.V., Leiden, the Netherlands .

出版信息

Nucleic Acid Ther. 2017 Jun;27(3):144-158. doi: 10.1089/nat.2016.0641. Epub 2017 Apr 4.

DOI:10.1089/nat.2016.0641
PMID:28375678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5467152/
Abstract

Clinical efficacy of antisense oligonucleotides (AONs) for the treatment of neuromuscular disorders depends on efficient cellular uptake and proper intracellular routing to the target. Selection of AONs with highest in vitro efficiencies is usually based on chemical or physical methods for forced cellular delivery. Since these methods largely bypass existing natural mechanisms for membrane passage and intracellular trafficking, spontaneous uptake and distribution of AONs in cells are still poorly understood. Here, we report on the unassisted uptake of naked AONs, so-called gymnosis, in muscle cells in culture. We found that gymnosis works similarly well for proliferating myoblasts as for terminally differentiated myotubes. Cell biological analyses combined with microscopy imaging showed that a phosphorothioate backbone promotes efficient gymnosis, that uptake is clathrin mediated and mainly results in endosomal-lysosomal accumulation. Nuclear localization occurred at a low level, but the gymnotically delivered AONs effectively modulated the expression of their nuclear RNA targets. Chloroquine treatment after gymnotic delivery helped increase nuclear AON levels. In sum, we demonstrate that gymnosis is feasible in proliferating and non-proliferating muscle cells and we confirm the relevance of AON chemistry for uptake and intracellular trafficking with this method, which provides a useful means for bio-activity screening of AONs in vitro.

摘要

反义寡核苷酸(AONs)治疗神经肌肉疾病的临床疗效取决于其有效的细胞摄取和在细胞内正确的靶向运输。通常基于化学或物理方法进行强制细胞递送,来选择体外效率最高的AONs。由于这些方法在很大程度上绕过了现有的膜通透和细胞内运输的天然机制,因此对AONs在细胞中的自发摄取和分布仍知之甚少。在此,我们报道了裸AONs在培养的肌肉细胞中的非辅助摄取,即所谓的裸寡核苷酸导入法。我们发现裸寡核苷酸导入法对增殖的成肌细胞和终末分化的肌管同样有效。细胞生物学分析与显微镜成像相结合表明,硫代磷酸酯骨架可促进有效的裸寡核苷酸导入,摄取是网格蛋白介导的,主要导致内体-溶酶体积累。核定位水平较低,但通过裸寡核苷酸导入法递送的AONs有效地调节了其核RNA靶点的表达。裸寡核苷酸导入后用氯喹处理有助于提高核AON水平。总之,我们证明了裸寡核苷酸导入法在增殖和非增殖肌肉细胞中是可行的,并且我们证实了这种方法中AON化学性质与摄取和细胞内运输的相关性,这为体外筛选AONs的生物活性提供了一种有用的手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/e38b9de6c71f/fig-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/70d78dbeacce/fig-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/ef5f0b906b94/fig-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/ccd59678fade/fig-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/65229179420b/fig-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/6e059b77899c/fig-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/e38b9de6c71f/fig-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/70d78dbeacce/fig-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/ef5f0b906b94/fig-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/ccd59678fade/fig-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/65229179420b/fig-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/6e059b77899c/fig-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbaf/5467152/e38b9de6c71f/fig-6.jpg

相似文献

1
Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro.体外成肌细胞和分化肌管中反义寡核苷酸在非辅助摄取后的细胞内分布及核活性
Nucleic Acid Ther. 2017 Jun;27(3):144-158. doi: 10.1089/nat.2016.0641. Epub 2017 Apr 4.
2
Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.2'-O-甲基硫代磷酸酯反义寡核苷酸的肽偶联增强 mdx 小鼠的心脏摄取和外显子跳跃。
Nucleic Acid Ther. 2014 Feb;24(1):25-36. doi: 10.1089/nat.2013.0448. Epub 2013 Dec 9.
3
Feasibility of SPECT-CT Imaging to Study the Pharmacokinetics of Antisense Oligonucleotides in a Mouse Model of Duchenne Muscular Dystrophy.SPECT-CT成像用于研究杜氏肌营养不良小鼠模型中反义寡核苷酸药代动力学的可行性
Nucleic Acid Ther. 2017 Aug;27(4):221-231. doi: 10.1089/nat.2016.0649. Epub 2017 Apr 18.
4
Dose-dependent pharmacokinetic profiles of 2'-O-methyl phosphorothioate antisense oligonucleotidesin mdx mice.mdx 小鼠中 2'-O-甲基硫代磷酸酯反义寡核苷酸的剂量依赖性药代动力学特征。
Nucleic Acid Ther. 2013 Jun;23(3):228-37. doi: 10.1089/nat.2012.0398. Epub 2013 May 2.
5
Advanced Fluorescence Imaging to Distinguish Between Intracellular Fractions of Antisense Oligonucleotides.先进的荧光成像技术用于区分反义寡核苷酸的细胞内组分
Methods Mol Biol. 2020;2063:119-138. doi: 10.1007/978-1-0716-0138-9_10.
6
Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.用于肌肉细胞中靶向DMD基因第46外显子跳跃的反义寡核苷酸类似物的比较分析
Gene Ther. 2004 Sep;11(18):1391-8. doi: 10.1038/sj.gt.3302313.
7
In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.2'-O-甲基硫代磷酸酯和吗啉代反义寡核苷酸用于杜氏肌营养不良症外显子跳跃的体内比较。
J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288.
8
Exonic sequences provide better targets for antisense oligonucleotides than splice site sequences in the modulation of Duchenne muscular dystrophy splicing.在杜氏肌营养不良症剪接的调控中,外显子序列比剪接位点序列为反义寡核苷酸提供了更好的靶点。
Oligonucleotides. 2010 Apr;20(2):69-77. doi: 10.1089/oli.2009.0215.
9
Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons.通过在一个或多个外显子内进行双重靶向探索杜氏肌营养不良症治疗性外显子跳跃的前沿领域。
Mol Ther. 2006 Sep;14(3):401-7. doi: 10.1016/j.ymthe.2006.02.022. Epub 2006 Jun 6.
10
DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.杜氏肌营养不良症假外显子突变:剪接效率、表型及潜在治疗方法
Ann Neurol. 2008 Jan;63(1):81-9. doi: 10.1002/ana.21290.

引用本文的文献

1
A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular anti-sense oligonucleotide activity.一项CRISPR/Cas9筛选揭示了在内体-高尔基体界面调节细胞反义寡核苷酸活性的蛋白质。
Nat Commun. 2025 Jun 30;16(1):5378. doi: 10.1038/s41467-025-61039-y.
2
Nucleic acid drugs: recent progress and future perspectives.核酸药物:最新进展与未来展望。
Signal Transduct Target Ther. 2024 Nov 29;9(1):316. doi: 10.1038/s41392-024-02035-4.
3
Hydrophobic CPP/HDO conjugates: a new frontier in oligonucleotide-warheaded PROTAC delivery.

本文引用的文献

1
CRISPR/Cas9-Induced (CTG⋅CAG) Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing.CRISPR/Cas9诱导的1型强直性肌营养不良基因座中(CTG⋅CAG)重复序列不稳定性:对治疗性基因组编辑的启示
Mol Ther. 2017 Jan 4;25(1):24-43. doi: 10.1016/j.ymthe.2016.10.014.
2
Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1.在小鼠和非人灵长类动物中鉴定和表征靶向强直性肌营养不良蛋白激酶(DMPK)的修饰反义寡核苷酸用于治疗1型强直性肌营养不良症
J Pharmacol Exp Ther. 2015 Nov;355(2):329-40. doi: 10.1124/jpet.115.226969. Epub 2015 Sep 1.
3
疏水性细胞穿透肽/疏水寡核苷酸缀合物:寡核苷酸导向的PROTAC递送新前沿。
RSC Med Chem. 2024 Sep 26;15(11):3695-703. doi: 10.1039/d4md00546e.
4
Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress.推进癌症治疗:基于寡核苷酸的疗法在推动进展中的作用。
Mol Ther Nucleic Acids. 2024 Jun 17;35(3):102256. doi: 10.1016/j.omtn.2024.102256. eCollection 2024 Sep 10.
5
Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo.定量分析 ASO 和 siRNA 缀合物在体内胶质母细胞瘤异种移植肿瘤中的活性谱。
Nucleic Acids Res. 2024 May 22;52(9):4799-4817. doi: 10.1093/nar/gkae260.
6
Peptide Conjugates of a 2'--Methoxyethyl Phosphorothioate Splice-Switching Oligonucleotide Show Increased Entrapment in Endosomes.2'-甲氧基乙基硫代磷酸酯剪接转换寡核苷酸的肽缀合物在内体中的包封率增加。
ACS Omega. 2023 Oct 17;8(43):40463-40481. doi: 10.1021/acsomega.3c05144. eCollection 2023 Oct 31.
7
Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1.1 型肌强直性营养不良反义疗法的研究进展与挑战
Int J Mol Sci. 2022 Nov 1;23(21):13359. doi: 10.3390/ijms232113359.
8
Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.控制主链化学和手性可增强寡核苷酸剪接切换活性。
Nucleic Acids Res. 2022 Jun 10;50(10):5443-5466. doi: 10.1093/nar/gkac018.
9
Renadirsen, a Novel 2'OMeRNA/ENA Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo.Renadirsen,一种新型 2'OMeRNA/ENA 嵌合反义寡核苷酸,在体内诱导肌营养不良蛋白外显子 45 的有效跳跃。
Curr Issues Mol Biol. 2021 Sep 25;43(3):1267-1281. doi: 10.3390/cimb43030090.
10
A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics.对研究 RNA 治疗药物细胞摄取和亚细胞定位方法的批判性分析。
Nucleic Acids Res. 2020 Aug 20;48(14):7623-7639. doi: 10.1093/nar/gkaa576.
Cellular uptake and intracellular trafficking of oligonucleotides.
寡核苷酸的细胞摄取与细胞内运输
Adv Drug Deliv Rev. 2015 Jun 29;87:35-45. doi: 10.1016/j.addr.2015.04.005. Epub 2015 Apr 14.
4
Cell membrane integrity in myotonic dystrophy type 1: implications for therapy.1型强直性肌营养不良症中的细胞膜完整性:对治疗的意义。
PLoS One. 2015 Mar 23;10(3):e0121556. doi: 10.1371/journal.pone.0121556. eCollection 2015.
5
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.短反义锁核酸(全锁核酸)可纠正强直性肌营养不良中的异常剪接。
Nucleic Acids Res. 2015 Mar 31;43(6):3318-31. doi: 10.1093/nar/gkv163. Epub 2015 Mar 9.
6
Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.鉴定和表征与硫代磷酸酯键连接的寡核苷酸结合的细胞内蛋白质。
Nucleic Acids Res. 2015 Mar 11;43(5):2927-45. doi: 10.1093/nar/gkv143. Epub 2015 Feb 20.
7
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.反义寡核苷酸的药代动力学、生物分布和细胞摄取。
Adv Drug Deliv Rev. 2015 Jun 29;87:46-51. doi: 10.1016/j.addr.2015.01.008. Epub 2015 Feb 7.
8
Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease.反义寡核苷酸介导的肌肉糖原合酶1合成抑制作为庞贝病底物减少疗法的一种方法。
Mol Ther Nucleic Acids. 2014 Oct 28;3(10):e206. doi: 10.1038/mtna.2014.57.
9
Understanding the process of fibrosis in Duchenne muscular dystrophy.了解杜氏肌营养不良症中的纤维化过程。
Biomed Res Int. 2014;2014:965631. doi: 10.1155/2014/965631. Epub 2014 May 4.
10
Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.寡核苷酸的细胞摄取和细胞内转运:对寡核苷酸药理学的启示。
Nucleic Acid Ther. 2014 Apr;24(2):101-13. doi: 10.1089/nat.2013.0463. Epub 2014 Jan 2.